Transdermal Drug Delivery System Market by Nervous System Disorders and Cardiovascular Diseases Rear Excessive Growth Estimated by Key Top Players Like Hisamitsu Pharmaceutical (Japan), Mylan (US), UCB (Belgium), Novartis (Switzerland), GlaxoSmithKline (U

Download Free PDF Brochure of Transdermal Drug Delivery System Market Report Now available at https://www.reportsnreports.com/contacts/requestsample.aspx?name=1844900 .

The key players in transdermal drug delivery systems market are Hisamitsu Pharmaceutical (Japan), Mylan (US), UCB (Belgium), Novartis (Switzerland), GlaxoSmithKline (UK), Boehringer Ingelheim (Germany), Johnson & Johnson (US), Endo International (Ireland), and Purdue Pharma (US).

The transdermal drug delivery systems market is expected to reach USD 7.1 billion by 2023 from an estimated USD 5.7 billion in 2018, at a CAGR of 4.5% during the forecast period. The growth of this market is primarily driven by factors such as the increase in the prevalence of chronic diseases and technological advancements in transdermal drug delivery systems.

Transdermal Drug Delivery Systems Market, By Type
1 Introduction
2 Transdermal Patches
6.2.1 Drug-In-Adhesive Patches
6.2.2 Matrix Patches
6.2.3 Reservoir Membrane Patches
6.2.4 Microneedle Patches
6.3 Transdermal Semisolids
6.3.1 Gels
6.3.2 Ointments
6.3.3 Sprays

Transdermal Drug Delivery Systems Market, By Application
7.1 Introduction
7.2 Pain Management
7.2.1 Pain Management to Account for the Largest Share of the Transdermal Drug Delivery Systems Market
7.3 Hormonal Applications
7.3.1 Testosterone Replacement Therapy
7.3.1.1 Skin Irritation, Poor Absorption of Drugs, High Costs, and the Need for Frequent Dosing are Factors Limiting Market Growth
7.3.2 Transdermal Estrogen Therapy
7.3.2.1 Growing Use of Transdermal Contraceptive Patches is Likely to Drive the Market for Transdermal Estrogen Therapy
7.4 Central Nervous System Disorders
7.4.1 Increasing Incidence of Parkinson’s and Alzheimer’s Disease to Drive the Market for Central Nervous System Disorders
7.5 Cardiovascular Diseases
7.5.1 Availability of Alternative and Advanced Drug Delivery Options to Limit Market Growth
7.6 Other Applications
7.6.1 Increasing Demand for Advanced Transdermal Microneedle Patches for Diabetes Management—A Key Market Driver

Transdermal Drug Delivery Systems Market, By End User8.1 Introduction
8.2 Home Care Settings
8.3 Hospitals & Clinics

Transdermal Drug Delivery Systems Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 Rising Prevalence of Targeted Disease and Development of Technologically Advanced Transdermal Drug Delivery Systems—Key Factors Driving Market Growth
9.2.2 Canada
9.2.2.1 Rising Prevalence of Chronic Diseases and Funding for the Development of Transdermal Drug Delivery Systems to Drive Market Growth
9.3 Europe
9.3.1 Germany
9.3.1.1 Growing Focus of Pharmaceutical Companies in Germany on the Development of Transdermal Products to Drive Market Growth
9.3.2 UK
9.3.2.1 Increasing Funding for the R&D of Innovative Transdermal Technologies to Drive Market Growth
9.3.3 France
9.3.3.1 Development of Transdermal Drug Delivery Systems By Local Players to Support Market Growth
9.3.4 RoE
9.4 Asia Pacific
9.4.1 Japan
9.4.1.1 Increasing Number of Product Approvals and Growing Focus of Local Players on R&D of Transdermal Systems to Support Market Growth
9.4.2 China
9.4.2.1 Growing Focus of Major Players in China Towards the Development of Transdermal Drug Delivery Systems to Drive Market Growth
9.4.3 India
9.4.3.1 Growing Awareness Among Healthcare Providers and Patients and Increasing Focus on Noninvasive Methods of Drug Delivery to Drive Market Growth
9.4.4 Ropac
9.5 RoW

More Information on Transdermal Drug Delivery System Market Top Trends and Company Profiles at https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1844900 .

North America, comprising the US and Canada, offers high-growth opportunities for players in the transdermal drug delivery systems market. This segment is slated to register the highest CAGR during the forecast period. Some of the factors driving market growth in the North American region are rising prevalence of targeted diseases (such as chronic pain, central nervous system disorders, and cardiovascular diseases) in the region, the increasing use of contraceptives, and the increasing number of research activities related to transdermal drug delivery systems.

The report analyzes the transdermal drug delivery systemsmarket and aims at estimating the market size and future growth potential of this market based on various segments such as applications, type, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–55%, Tier 2–25% and Tier 3–20%
• By Designation – C-level–43%, Director Level–32%, Others–25%
• By Region – North America–38%, Europe–29%, Asia Pacific–23%, RoW–10%

The report analyzes the transdermal drug delivery systemsmarket and aims at estimating the market size and future growth potential of this market based on various segments such as applications, type, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

You can place the oder here now at “Transdermal Drug Delivery System Market by Type (Patches and Semisolid formulations), Applications (Pain Management, Central Nervous System Disorders, Hormonal Applications, Cardiovascular Diseases), End User, and Region - Global Forecast to 2023” research https://www.reportsnreports.com/purchase.aspx?name=1844900 .

North America is the major revenue generating region in the transdermal drug delivery systems market. The transdermal drug delivery systems market in the region is driven by the rising prevalence of targeted diseases (such as chronic pain, central nervous system disorders, and cardiovascular diseases) in the region, the increasing use of contraceptives, and the increasing number of research activities related to transdermal drug delivery systems.

Company Profiles (Business Overview, Products Offered, Recent Developments)
1 Hisamitsu Pharmaceutical Co., Inc.
2 Mylan N.V.
3 UCB S.A.
4 Novartis AG
5 Glaxosmithkline PLC
6 Boehringer Ingelheim International GmbH
7 Johnson & Johnson (J&J)
8 Endo International, Inc.
9 Purdue Pharma L.P.
10 Lavipharm
11 Lead Chemicals Co., Inc.
12 Luye Pharma Group

ReportsnReports is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

Contact Number: + 1 888 391 5441
Email Id - sales@reportsandreports.com

This release was published on openPR.